Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leukocytes and with quantitative PCR.
BACKGROUND
Human cytomegalovirus (HCMV) infection poses a significant health threat to immunocompromised individuals. Here we performed this study to set up a highly sensitive nested PCR method applicable for detecting HCMV infection in high-risk individuals. In this work, 106 blood specimens from 66 patients with potential HCMV infection were obtained. Total DNA was extracted separately from plasma and peripheral blood leukocytes (PBL) of each sample. HCMV DNA was detected in parallel by nested PCR and quantitative real-time PCR (qRT-PCR), and the results were compared.


RESULTS
Serial dilution test revealed that the detection limit of nested PCR was 180 copies/ml. The nested PCR showed a higher positive rate than qRT-PCR (34.9% vs. 12.3%, p < 0.001). The positive rate of nested PCR based on PBL DNA was significantly higher than that based on plasma DNA (34.9% vs. 18.9%, p = 0.002). Of the 14 patients with serial samples, 11 were positive for HCMV DNA in PBL while only 7 were positive in plasma. Moreover, for each patient, nested PCR using PBL DNA also detected more positive samples than that using plasma DNA.


CONCLUSIONS
Combined use of nested PCR with PBL DNA is highly sensitive in defining HCMV infection. This assay is particularly useful in the case of quantification not essential.
Zhang
Shu
S
Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Zhou
Yi-Hua
YH
Li
Lei
L
Hu
Yali
Y
D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000821:virology; D006801:Humans; D007962:Leukocytes / Q000821:virology*; D010949:Plasma / Q000821:virology*; D016133:Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D014773:Virology / Q000379:methods*
J Paediatr Child Health. 2008 Apr;44(4):166-9
17854407
Virus Res. 2008 Feb;131(2):160-9
17963941
Transplant Proc. 2009 Sep;41(7):2898-9
19765467
Pathol Oncol Res. 2008 Dec;14(4):399-409
18392952
J Clin Virol. 2006 Dec;37(4):313-6
17035082
Transplantation. 1997 Jul 15;64(1):108-13
9233710
Med Microbiol Immunol. 2009 May;198(2):107-12
19308446
J Virol Methods. 2008 Jul;151(1):55-60
18462812
Mol Biotechnol. 2008 Jan;38(1):65-70
18095191
Clin Vaccine Immunol. 2009 Nov;16(11):1700-3
19776197
J Med Virol. 2005 May;76(1):76-81
15778970
Oral Microbiol Immunol. 2008 Jun;23(3):239-44
18402611
J Med Virol. 1996 May;49(1):61-5
8732861
BMC Infect Dis. 2004 Nov 30;4:55
15571633
Diagn Mol Pathol. 2008 Sep;17(3):166-73
18382366
J Clin Microbiol. 2003 Aug;41(8):3840-5
12904398
J Clin Microbiol. 2008 Mar;46(3):943-6
18199787
J Clin Microbiol. 2003 Sep;41(9):4382-7
12958273
Int J Antimicrob Agents. 2004 Nov;24(5):455-62
15519477
J Clin Microbiol. 2008 Jun;46(6):1897-900
18400914
Clin Microbiol Rev. 2002 Oct;15(4):680-715
12364375
J Virol Methods. 2008 Jul;151(1):61-5
18462815
J Clin Microbiol. 1998 Apr;36(4):1008-14
9542927
J Clin Microbiol. 2008 Oct;46(10):3311-8
18753357
Transplant Proc. 2004 Dec;36(10):3036-41
15686689
J Virol Methods. 2008 Jul;151(1):47-54
18479760
Transpl Infect Dis. 2007 Mar;9(1):16-21
17313466
J Virol Methods. 2003 Jun 9;110(1):73-9
12757923
J Virol Methods. 2001 Jul;96(1):25-31
11516486
J Infect. 2005 Feb;50(2):130-7
15667914
J Clin Virol. 2003 Jan;26(1):49-59
12589834
J Clin Virol. 2004 Feb;29(2):71-83
14747024
J Med Virol. 1994 Dec;44(4):317-22
7897362
J Med Microbiol. 2009 Jul;58(Pt 7):878-883
19502375
Am J Transplant. 2009 Feb;9(2):258-68
19178413
Nature. 1989 May 18;339(6221):237-8
2716852
J Virol Methods. 2007 Jul;143(1):23-8
17336402
J Clin Microbiol. 2002 Nov;40(11):4203-6
12409398